ZHFX3 and BIRC6 can promote the proliferation of tumor cells, meaning that the mutation or knockout of these can inhibit the progression of cancer, resulting in a prolonged OS (Hao et al., 2020; Zhang et al., 2021). Here, BIRC6 is linked to cancer.